According to Cardiac Healthcare, recently, the company's Hector® /Tsutenji® thoracic aortic multi-branch laminating stent system and Cratos® /Tsutensana® branched aortic stent system successfully completed their first clinical application at Toronto General Hospital in Canada, achieving the first commercial implementation of the company's products in Canada.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.